Specialists rely on the hyperhidrosis severity scale to assess the seriousness of the situation, as well as the discomfort in order to find an appropriate treatment. Treatments to consider The first ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

The Company believes DMT410 has the potential be to a first-in-class treatment for hyperhidrosis, acne, and facial aesthetics. As of September 30, 2024, the Company had $6.1 million in cash and cash ...

Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

Doctors have been fairly quick to jump on the biologics train: According to Spherix, 96% of dermatologists reported using ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...

Botox, a muscle relaxer derived from bacteria, has gained popularity as a safe and effective anti-aging treatment. It smooths ...

Botanix Pharmaceuticals Limited (AU:BOT) has released an update. Botanix Pharmaceuticals Limited is set to make waves in the dermatology market ...

Botox is one of the significant advances in dealing with hyperhidrosis: a practical, noninvasive, and long-term solution to a situation that, properly allowed to develop, can adversely affect ...

Dry, Inc., a leader in excessive underarm sweat treatment, proudly celebrates Hyperhidrosis Awareness Month this November by reinforcing its commitment to supporting those affected by hyperhidrosis.